MeSH tree: G11.561.645
More than a decade of new knowledge about neurodevelopmental risk in people with congenital heart disease has changed the thinking about who is most at risk and the factors that impact neurological development, learning, ...
Feb 22, 2024
0
39
Although primary open-angle glaucoma (POAG) is the leading cause of blindness in people over the age of 55, there remains no cure for the disease and its biological mechanisms are not well understood. Elevated intraocular ...
Feb 16, 2024
0
67
People with ischemic (clot-caused) stroke had better early recovery of cognitive function if treated with intravenous injections of a combination of biologically active components of ginkgo biloba during the first two weeks ...
Feb 1, 2024
0
47
CAMH-led pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis (MS). The results have been published in the journal Science Advances.
Dec 8, 2023
0
238
Patients with altered level of consciousness are among the most difficult to assess and may have subtle neurological changes that can occur suddenly and become life-threatening if they go unnoticed.
Aug 1, 2023
0
35
International research led by QIMR Berghofer has found hundreds of new genes linked to a person's risk of developing glaucoma, including key genetic targets that could, for the first time, pave the way for treatments that ...
Jul 3, 2023
0
166
New research suggests that having a stronger purpose in life (PiL) may promote cognitive resilience among middle-aged adults. Cognitive resilience refers to the capacity of the brain to cope with stressors, injuries and pathology, ...
Apr 19, 2023
0
121
A team of experts encouraged ongoing investigation of the benefits of exercise training for individuals with multiple sclerosis, citing shortcomings of available studies. They outlined their outlook for this avenue of research ...
Jul 19, 2022
0
80
